🟢 GE HealthCare is trading 4.12% up in pre-market after Q3 beat and raised full-year outlook

GE HealthCare is trading 4.12% up at $74.04 after third-quarter results beat expectations and it raised its full-year outlook.

• Revenue grew 7.2%, broadly across segments, with strong Pharmaceutical Diagnostics and Advanced Imaging Solutions performance, margin expansion and robust cash flow.
• Reuters reported the quarterly beat and said GE HealthCare is weighing a possible Patient Care segment sale.
• The earnings release was scheduled before the market open on October 28.